MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
DexCom EV - Enterprise Value 2011-2026 | DXCM
Annual EV - Enterprise Value DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.2 B | 29.5 B | 52.4 B | 44.7 B | 53.8 B | 36.5 B | 22.8 B | 12.8 B | 5.16 B | 6.59 B | 5.67 B | 4.47 B | 2.79 B | 1.06 B | 735 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.8 B | 735 M | 20.5 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
1.01 B | $ 9.19 | 2.06 % | $ 612 M |  USA |
|
Biodesix
BDSX
|
142 M | $ 15.31 | 4.22 % | $ 1.99 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 74.11 | -2.15 % | $ 5 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 463.46 | 1.43 % | $ 13.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 159.84 | 1.16 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 165.65 | -0.81 % | $ 28.5 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.67 | 0.11 % | $ 432 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 17.26 | -1.46 % | $ 386 M | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
34.1 M | $ 1.22 | -16.44 % | $ 6.64 M | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 261.71 | 1.72 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 125.17 | 1.11 % | $ 19.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.38 | -1.08 % | $ 414 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
10.9 M | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Celcuity
CELC
|
506 M | $ 101.12 | -5.27 % | $ 3.99 B | USA |
 |
Personalis
PSNL
|
229 M | $ 7.67 | 0.72 % | $ 454 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 266.56 | 0.81 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
7.26 B | $ 59.22 | -4.09 % | $ 4.45 B | USA |
 |
ENDRA Life Sciences
NDRA
|
864 K | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 7.87 | -2.82 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
5.53 B | $ 193.75 | -3.17 % | $ 19.1 B | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.63 | 0.08 % | $ 277 M | USA |
 |
Sotera Health Company
SHC
|
7.07 B | $ 13.82 | -0.43 % | $ 3.92 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 17.65 | 0.51 % | $ 941 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 30.84 | -2.77 % | $ 1.57 B | USA |
 |
OPKO Health
OPK
|
1.62 B | $ 1.14 | -1.3 % | $ 791 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 25.23 | -2.02 % | $ 701 M | USA |
 |
DarioHealth Corp.
DRIO
|
11 M | $ 8.05 | 7.27 % | $ 32.1 M | Israel |
 |
Neuronetics
STIM
|
168 M | $ 1.47 | -8.12 % | $ 96.9 M | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | $ 104.91 | - | $ 19.8 B | USA |